Navigation Links
Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis
Date:2/27/2008

autoimmune disease characterized by inflammation in the lining of joints (or synovium), causing joint damage with chronic pain, stiffness, and swelling.(1) RA causes limited range of motion and decreased function as a result of affected joints losing their shape and alignment.(3)

RA affects about 1 percent of the world's population,(4) including more than two million adults in the United States.(1) In this population, ORENCIA(R) (abatacept) is indicated to treat adults with moderately to severely active RA who have had an inadequate response to one or more DMARDs.(5) The condition is more common in women than in men, who account for 75 percent of patients diagnosed with RA.(1)

About the Survey

The survey is based on 340 telephone interviews conducted among Americans living with rheumatoid arthritis who were 18 years of age and older. Of this group, 128 interviews were completed with people who have rheumatoid arthritis and who have experienced an inadequate response to some biologic and non-biologic disease-modifying anti-rheumatic drugs (DMARDs).(2) The results reflected in this release represent this patient population of 128 people. All interviews were conducted in March, April and May 2007.(2) GfK Roper Public Affairs & Media, part of GfK Custom Research North America, conducted the survey on behalf of Bristol-Myers Squibb.

About ORENCIA(R) (abatacept)

ORENCIA is a prescription medicine that is used to treat adults with moderate-to-severe rheumatoid arthritis (RA) who have not been helped enough by other medicines for RA. A doctor may consider treatment with ORENCIA because the patient's disease is still active even though they may have tried other treatments. ORENCIA can be used alone or with other agents. ORENCIA should not be taken with biologic medications for RA such as Enbrel(R), Humira(R), Remicade(R), or Kineret(R).

Dosing and Administration

ORENCIA is administered by a healthcare professional as a 30-min
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Celebrity Seating Only! Levitz Chair Signed by 39 Daytime Stars Sells for $1200 on Charitybuzz.com
2. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
3. American Airlines 13th Annual Celebrity Golf and Tennis Weekend Will Raise Funds to Fight Breast Cancer
4. New Celebrity Introduces Students to Need, Advantages of Health Care Careers
5. VH1 Teams Up with Dr. Drew for Celebrity Rehab With Dr. Drew, a Series Depicting the Process of Overcoming Addiction
6. Largest Celebrity Memorabilia Auction Honors World AIDS Day
7. Celebrity Influences on Plastic Surgery
8. Sopranos Star Vincent Pastore Wins 50 Big Ones for Lustgarten Foundation on NBCs The Celebrity Apprentice
9. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour to L.A.
10. Bone Crusher, the King of VH1s Celebrity Fit Club With the Record of Biggest Individual Weight Loss, Releases Fitness DVD!
11. Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 2Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 3Health News:Hurricane Devastation Touches the Nation's Blood Supply 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 2Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 4Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 5Health News:New High Performance Brushless dc Motors From NMB 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 3
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3TeamStaff Inc To Announce Third Quarter Results 54190 1TeamStaff Inc To Announce Third Quarter Results 54190 2TeamStaff Inc To Announce Third Quarter Results 54190 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 1Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 2Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 4Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 5Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 6Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 7Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 8Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 9Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 10Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 11Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 12Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 13ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 1ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 2